More recent trends are focusing on the identification of primary cell signaling pathways that trigger the downstream mechanism of epilepsy, such as the mammalian target of rapamycin (mTOR) pathway, which is increasingly recognized to be involved in a diverse group of human diseases such as cancer, cardiovascular diseases, diabetes, obesity, and neurological disorders [21]. This evidence concerns the gene MTOR and diabetes mellitus.